<DOC>
	<DOCNO>NCT00861562</DOCNO>
	<brief_summary>The purpose study assess clinical efficacy safety drug Imescard water smartweed compound pill treatment patient chronic constipation hemorrhoidal disease .</brief_summary>
	<brief_title>Clinical Efficacy Safety Evaluation Drug Imescard Compound Water Smartweed Pills</brief_title>
	<detailed_description>The Imescard compound water smartweed pill currently register Brazil National Sanitary Surveillance Agency ( ANVISA ) laxative treatment constipation , support drug hemorrhoid treatment . Though water smartweed ( Polygonum hydropiperoides ) use throughout year antiinflammatory hemorrhoidal treatment , reliable pharmacologic clinical evidence demonstrate efficacy . The aim study assess clinical efficacy safety drug Imescard compound water smartweed pill treatment chronic constipation hemorrhoidal disease randomize , double-blind , crossover , placebo-controlled clinical trial . Volunteers underwent clinical evaluation laboratory exam enrollment , 56 patient meet inclusion criterion agree sign inform consent form . Participants randomize two group receive either Imescard pill placebo , identical appearance , every 8 hour five day , follow 10-day washout period , receive intervention another 5-day period . Followup visit perform day 1 , 5 , 15 , 19 . At begin intervention period ( day 1 15 ) , patient give diary include two questionnaire day treatment , concern constipation hemorrhoidal symptom , receive intervention , unaware content . Colonic transit time assessed end intervention period ( day 5 19 ) standard radiologic technique , laboratory exam take three day later . Clinical evaluation adverse effect assessment perform every visit blind investigator , patient also fulfil WHOQOL Brief , life quality assessment .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>age 18 50 ; chronic constipation diagnosis American Association Gastroentherology ( AAG ) criterion ; clinical diagnosis first second degree hemorrhoid ; good understanding collaboration skill ; correct fulfil questionnaire recruiting phase ; absence abnormality laboratory exams recruiting phase ; proper use anticonceptives , case woman fertile age ; possibility abstain drug ( include nonmedical one ) intervention study , except case emergency awareness responsible party study ; sign informed consent form . Pregnant lactating woman ; know hypersensitivity intervention 's component ; use alcohol illicit substance ; clinical evidence immunosuppression ; diagnosis acute disease activity exacerbation chronic condition ( uncontrolled ) , systemic arterial hypertension , ischemic cardiopathy , angle closure glaucoma , symptomatic prostatic hyperplasia , concomitant anal disease fissure , abscess , fistula , inflammatory bowel disease colonic rectal cancer , well condition , investigator 's opinion , may modify study result unduly intervention test may put patient significant risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>constipation</keyword>
	<keyword>hemorrhoid</keyword>
	<keyword>water smartweed</keyword>
	<keyword>RCT</keyword>
</DOC>